the efficiency of using α-glucosidase inhibitors in patients with diabetes mellitus type 2 and obesity
Clicks: 245
ID: 186312
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
8.4
/100
28 views
28 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The article presents the results of studying the impact of α-glucosidase inhibitors on body weight and main carbohydrate metabolism indicators. The authors note the positive effects of drugs from this group on all components of metabolic syndrome, safety for the body, absence of serious contraindications and low level of hypoglycemia. Voglibose as representative of α-glucosidase inhibitors can be effectively used in combination with metformin, as well as together with insulin therapy.
| Reference Key |
pasiechko2015mnarodnijthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;N.V. Pasiechko;H.Ya. Loi;L.P. Mazur;I.P. Savchenko |
| Journal | Macromolecular rapid communications |
| Year | 2015 |
| DOI |
10.22141/2224-0721.2.66.2015.75444
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.